Why We Need Biomarkers in Psychiatry
Consensus statement outlines how standardized, validated biological tests could move psychiatric diagnosis and treatment beyond symptom-based classification
Clinical Scorecard: Why We Need Biomarkers in Psychiatry
At a Glance
| Category | Detail |
|---|
| Condition | Psychiatric Disorders |
| Key Mechanisms | Biological and environmental interactions |
| Target Population | Patients with psychiatric disorders |
| Care Setting | Clinical trials and routine care |
Key Highlights
- Need for standardization and validation of psychiatric biomarkers
- Current reliance on symptom-based patient recruitment in clinical trials
- Proposed framework for moving biomarkers from discovery to clinical use
- Importance of analytical validation for candidate tests
- Potential applications include predicting treatment response and monitoring safety
Guideline-Based Recommendations
Diagnosis
- Incorporate biomarkers into clinical trials with sufficient analytical validation
Management
- Use a combination of measurements for more informative results
Monitoring & Follow-up
- Focus on safety monitoring and treatment response prediction
Risks
- Insufficient analytical validation may limit clinical interpretation
Patient & Prescribing Data
Patients with varying psychiatric disorders
Biomarkers may help identify patient subgroups for tailored treatment
Clinical Best Practices
- Engage regulators early in the biomarker development process
- Establish common data elements and harmonized protocols across studies
- Ensure tests fit into laboratory and healthcare workflows
Related Resources & Content
